Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 15 of 224 results for dementia

  1. Dementia: assessment, management and support for people living with dementia and their carers (NG97)

    This guideline covers diagnosing and managing dementia (including Alzheimer’s disease). It aims to improve care by making recommendations on training staff and helping carers to support people living with dementia.

  2. Dementia (QS184)

    This quality standard covers preventing dementia, and assessment, management and health and social care support for people with dementia. It describes high-quality care in priority areas for improvement.

  3. Dementia

    All NICE products on dementia. Includes any guidance and quality standards.

  4. Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset (NG16)

    This guideline covers mid-life approaches to delay or prevent the onset of dementia, disability and frailty in later life. The guideline aims to increase the amount of time that people can be independent, healthy and active in later life.

  5. Dementia – discussing and planning support after diagnosis

    A quick guide for people with dementia and their family and carers A diagnosis of dementia may create very mixed emotions....

  6. NICEimpact dementia

    How NICE recommendations are being used to improve outcomes in priority areas of dementia care

  7. Commentary - dementia

    are diagnosed with dementia, but up to a third of people living with dementia may not have a formal diagnosis. NICE has...

  8. Prevent or delay the onset of dementia

    NICE's impact on preventing or delaying the onset of dementia

  9. Dementia. Patient decision aid on enteral (tube) feeding for people living with severe dementia

    Decision aid for Dementia: assessment, management and support for people living with dementia and their carers c NICE 2018....

  10. Dementia: care planning (IND142)

    This indicator covers the percentage of patients diagnosed with dementia whose care plan has been reviewed in a face-to-face review in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM107

  11. Hydromethylthionine mesylate for treating mild cognitive impairment or mild or moderate dementia caused by Alzheimer's disease [ID6343]

    In development [GID-TA11379] Expected publication date: 30 April 2025

  12. Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]

    In development [GID-TA11221] Expected publication date: TBC

  13. Dementia. Patient decision aid on antipsychotic medicines for treating agitation, aggression and distress in people living with dementia

    Decision aid for Dementia: assessment, management and support for people living with dementia and their carers c NICE 2018....

  14. Dementia: target organ damage (all patients) (IND118)

    This indicator covers the percentage of patients with dementia (diagnosed on or after 1 April 2014) with a record of FBC, calcium, glucose, renal and liver function, thyroid function tests, serum vitamin B12 and folate levels recorded up to 12 months before entering on to the register. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM72

  15. Dementia: anti-psychotic prescriptions (IND12)

    This indicator covers the proportion of people with dementia prescribed anti-psychotic medication. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG18